litlas
ログインアカウント作成

Marwan N. Sabbagh

1997–2025 年に発表

別表記
Marwan N Sabbagh
179
論文数
30,010
被引用数
92
h 指数
171
i10 指数

被引用数

Marwan N. Sabbagh の年別被引用数1967 年: 被引用 2 件1988 年: 被引用 2 件1990 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 5 件1999 年: 被引用 1 件2000 年: 被引用 6 件2001 年: 被引用 10 件2002 年: 被引用 13 件2003 年: 被引用 12 件2004 年: 被引用 17 件2005 年: 被引用 39 件2006 年: 被引用 70 件2007 年: 被引用 66 件2008 年: 被引用 125 件2009 年: 被引用 145 件2010 年: 被引用 211 件2011 年: 被引用 249 件2012 年: 被引用 305 件2013 年: 被引用 342 件2014 年: 被引用 390 件2015 年: 被引用 414 件2016 年: 被引用 452 件2017 年: 被引用 433 件2018 年: 被引用 419 件2019 年: 被引用 1,171 件2020 年: 被引用 1,470 件2021 年: 被引用 1,583 件2022 年: 被引用 1,462 件2023 年: 被引用 1,103 件2024 年: 被引用 1,667 件2025 年: 被引用 932 件2026 年: 被引用 31 件1968〜1987 年は被引用が無いため表示していません1989 年は被引用が無いため表示していません1991〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,575 件、この内訳の 25.7%イギリス: 引用元論文 1,426 件、この内訳の 8%中国: 引用元論文 1,373 件、この内訳の 7.7%ドイツ: 引用元論文 877 件、この内訳の 4.9%イタリア: 引用元論文 767 件、この内訳の 4.3%カナダ: 引用元論文 723 件、この内訳の 4.1%スペイン: 引用元論文 619 件、この内訳の 3.5%オーストラリア: 引用元論文 592 件、この内訳の 3.3%スウェーデン: 引用元論文 592 件、この内訳の 3.3%フランス: 引用元論文 534 件、この内訳の 3%オランダ: 引用元論文 469 件、この内訳の 2.6%インド: 引用元論文 461 件、この内訳の 2.6%
0%25.7%その他 27%

機関

分野

  • Medicine68.3%
  • Neuroscience13.3%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Computer Science1.8%
  • Engineering0.6%
  • Health Professions0.5%
  • その他4%

トピック

  • Alzheimer's disease research and treatments15.5%
  • Dementia and Cognitive Impairment Research8.9%
  • Parkinson's Disease Mechanisms and Treatments5.7%
  • Cholinesterase and Neurodegenerative Diseases3.8%
  • Neuroinflammation and Neurodegeneration Mechanisms3.2%
  • Neurological disorders and treatments3.1%
  • その他59.8%

共著者

全論文

検索で開く
  1. Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021

    著者: Anton P. Porsteinsson, Richard Isaacson, S. Knox, Marwan N. Sabbagh, I. Alex Rubino - The Journal of Prevention of Alzheimer s Disease 2021 被引用: 691

  2. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    著者: Stephen Salloway, Reisa A. Sperling, Nick C. Fox, Kaj Blennow, William E. Klunk, Murray A. Raskind, Marwan N. Sabbagh, Lawrence S. Honig, Anton P. Porsteinsson, Steven H. Ferris, Marcel Reichert, Nzeera Ketter, Bijan Nejadnik, Volkmar Guenzler, Maja Miloslavsky, Daniel Wang, Yuan Lü, Julia Lull, Iulia Cristina Tudor, Enchi Liu, Michael Grundman, Eric Yuen, Ronald S. Black, H. Robert Brashear - New England Journal of Medicine 2014 被引用: 1,965

  3. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis

    著者: Jerome Liss, Sheila Seleri Assunção, James J. Cummings, Alireza Atri, David Geldmacher, S. F. Candela, Davangere P. Devanand, Howard Fillit, Jeffrey Susman, Jacobo Mintzer, T. Bittner, Stephen Brunton, Diana Kerwin, Will Jackson, Gary W. Small, George T. Grossberg, Caroline Clevenger, Valerie T. Cotter, Richard G. Stefanacci, Alexandria Wise-Brown, Marwan N. Sabbagh - Journal of Internal Medicine 2021 被引用: 310

  4. Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program

    著者: Thomas G. Beach, Charles H. Adler, Lucia I. Sue, Geidy E. Serrano, Holly A. Shill, Douglas G. Walker, Lih‐Fen Lue, Alex E. Roher, Brittany N. Dugger, Chera L. Maarouf, Alex C. Birdsill, Anthony J. Intorcia, Megan Saxon‐LaBelle, Joel Pullen, Alexander Scroggins, Jessica Filon, Sarah Scott, Brittany Hoffman, Angelica Garcia, John N. Caviness, Joseph G. Hentz, Erika Driver‐Dunckley, Sandra A. Jacobson, Kathryn Davis, Christine M. Belden, Kathy E. Long, Michael Malek‐Ahmadi, Jessica Powell, Lisa D. Gale, Lisa R. Nicholson, Richard J. Caselli, Bryan K. Woodruff, Steven Z. Rapscak, Geoffrey L. Ahern, Jiong Shi, Anna Burke, Eric M. Reiman, Marwan N. Sabbagh - Neuropathology 2015 被引用: 503

  5. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

    著者: Thomas G. Beach, Charles H. Adler, Lih‐Fen Lue, Lucia I. Sue, Jyothi Bachalakuri, Jonette Henry-Watson, Jeanne Sasse, Sarah Boyer, Scophil Shirohi, R. Brooks, Jennifer Eschbacher, Charles L. White, Haru Akiyama, John N. Caviness, Holly A. Shill, Donald J. Connor, Marwan N. Sabbagh, Douglas G. Walker - Acta Neuropathologica 2009 被引用: 701

  6. Aducanumab: Appropriate Use Recommendations Update

    著者: Jeffrey L. Cummings, Gil D. Rabinovici, Alireza Atri, Paul Aisen, Liana G. Apostolova, Suzanne Hendrix, Marwan N. Sabbagh, Dennis J. Selkoe, Michael W. Weiner, Stephen Salloway - The Journal of Prevention of Alzheimer s Disease 2022 被引用: 194

  7. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

    著者: Reisa A. Sperling, Stephen Salloway, David J. Brooks, Donatella Tampieri, Jerome Barakos, Nick C. Fox, Murray A. Raskind, Marwan N. Sabbagh, Lawrence S. Honig, Anton P. Porsteinsson, Ivan Lieberburg, H. Michael Arrighi, Kristen Morris, Yuan Lü, Enchi Liu, Keith M. Gregg, H. Robert Brashear, Gene G. Kinney, Ronald S. Black, Michael Grundman - The Lancet Neurology 2012 被引用: 510

  8. Aducanumab, gantenerumab, BAN2401, and ALZ-801—the first wave of amyloid-targeting drugs for Alzheimer’s disease with potential for near term approval

    著者: Martin Tolar, Susan Abushakra, John A. Hey, Anton P. Porsteinsson, Marwan N. Sabbagh - Alzheimer s Research & Therapy 2020 被引用: 356

  9. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

    著者: Osama Sabri, Marwan N. Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao, Thomas G. Beach, Christopher C. Rowe, James B. Leverenz, Bernardino Ghetti, James W. Ironside, Ana M. Catafau, Andrew Stephens, André Mueller, Norman Koglin, Anja Hoffmann, Katrin Roth, Cornelia Reininger, Walter Schulz‐Schaeffer, Florbetaben Phase 3 Study Group - Alzheimer s & Dementia 2015 被引用: 609

  10. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

    著者: Thomas G. Beach, Charles H. Adler, Lucia I. Sue, Linda Vedders, Lih Fen Lue, Charles L. White, Haru Akiyama, John N. Caviness, Holly A. Shill, Marwan N. Sabbagh, Douglas G. Walker - Acta Neuropathologica 2010 被引用: 900

  11. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

    著者: Christopher M. Clark, Michael J. Pontecorvo, Thomas G. Beach, Barry J. Bedell, Robert E. Coleman, P. Murali Doraiswamy, Adam Fleisher, Eric M. Reiman, Marwan N. Sabbagh, Carl Sadowsky, Julie A. Schneider, Anupa Arora, Alan Carpenter, Matthew Flitter, Abhinay D. Joshi, Michael J. Krautkramer, Ming‐Chi Lu, Mark A. Mintun, Daniel Skovronsky - The Lancet Neurology 2012 被引用: 848

  12. The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis

    著者: Martin Tolar, Susan Abushakra, Marwan N. Sabbagh - Alzheimer s & Dementia 2019 被引用: 283

  13. Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force

    著者: Davide Angioni, Julien Delrieu, Oskar Hansson, Howard Fillit, Paul Aisen, Jeffrey L. Cummings, John R. Sims, Joel B. Braunstein, Marwan N. Sabbagh, T. Bittner, Michael J. Pontecorvo, Sasha Bozeat, Jeffrey L. Dage, Emily A. Largent, Soeren Mattke, O. Correa, Laura Robledo, V. Baldivieso, Deanna Willis, Alireza Atri, Randall J. Bateman, P-J. Ousset, Bruno Vellas, Michael W. Weiner - The Journal of Prevention of Alzheimer s Disease 2022 被引用: 123

  14. Alzheimer's disease drug development pipeline: 2020

    著者: Jeffrey L. Cummings, Garam Lee, Aaron Ritter, Marwan N. Sabbagh, Kate Zhong - Alzheimer s & Dementia Translational Research & Clinical Interventions 2020 被引用: 554

  15. Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

    著者: Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck, Reisa A. Sperling, Steven M. Hersch, André Matta, Luigi Giorgi, Michelle Gee, Michio Kanekiyo, David Li, Derk D. Purcell, Shobha Dhadda, Michael C. Irizarry, Lynn D. Kramer - Alzheimer s Research & Therapy 2024 被引用: 145

  16. Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease

    著者: Boris Decourt, Debomoy K. Lahiri, Marwan N. Sabbagh - Current Alzheimer Research 2016 被引用: 373

  17. Low clinical diagnostic accuracy of early vs advanced Parkinson disease

    著者: Charles H. Adler, Thomas G. Beach, Joseph G. Hentz, Holly A. Shill, John N. Caviness, Erika Driver‐Dunckley, Marwan N. Sabbagh, Lucia I. Sue, Sandra A. Jacobson, Christine M. Belden, Brittany N. Dugger - Neurology 2014 被引用: 500

  18. Early Detection of Mild Cognitive Impairment (MCI) in Primary Care

    著者: Marwan N. Sabbagh, Merçé Boada, Soo Borson, M. Chilukuri, Bruno Dubois, John C. L. Ingram, Atsushi Iwata, Anton P. Porsteinsson, Katherine L. Possin, Gil D. Rabinovici, Bruno Vellas, S Chao, Andrea Vergallo, Harald Hampel - The Journal of Prevention of Alzheimer s Disease 2020 被引用: 206

  19. Alzheimer's disease drug development pipeline: 2019

    著者: Jeffrey L. Cummings, Garam Lee, Aaron Ritter, Marwan N. Sabbagh, Kate Zhong - Alzheimer s & Dementia Translational Research & Clinical Interventions 2019 被引用: 763

  20. Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015

    著者: Dev Mehta, Robert Jackson, Gaurav Paul, Jiong Shi, Marwan N. Sabbagh - Expert Opinion on Investigational Drugs 2017 被引用: 621

  21. Lecanemab (BAN2401): an anti–beta-amyloid monoclonal antibody for the treatment of Alzheimer disease

    著者: Grace Vitek, Boris Decourt, Marwan N. Sabbagh - Expert Opinion on Investigational Drugs 2023 被引用: 116

  22. Optimal deep brain stimulation sites and networks for stimulation of the fornix in Alzheimer’s disease

    著者: Ana Sofía Ríos, Simón Oxenford, Clemens Neudorfer, Konstantin Butenko, Ningfei Li, Nanditha Rajamani, Alexandre Boutet, Gavin J.B. Elias, Jürgen Germann, Aaron Loh, Wissam Deeb, Fuyixue Wang, Kawin Setsompop, Bryan Salvato, Leonardo Almeida, Kelly D. Foote, Robert Amaral, Paul B. Rosenberg, David F. Tang‐Wai, David A. Wolk, Anna Burke, Stephen Salloway, Marwan N. Sabbagh, M. Mallar Chakravarty, Gwenn S. Smith, Constantine G. Lyketsos, Michael S. Okun, William S. Anderson, Zoltán Mari, Francisco A. Ponce, Andrés M. Lozano, Andreas Horn - Nature Communications 2022 被引用: 100

  23. Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease

    著者: Aaron H. Burstein, Marwan N. Sabbagh, Rachel M. Andrews, Carmen Valcarce, Imogene Dunn, L. Altstiel - The Journal of Prevention of Alzheimer s Disease 2018 被引用: 152

  24. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

    著者: Alex E. Roher, Chera L. Esh, Tyler A. Kokjohn, Eduardo M. Castaño, Gregory D. Van Vickle, Walter M. Kalback, Rebekah Patton, Dean C. Luehrs, Ian D. Daugs, Yu‐Min Kuo, Mark R. Emmerling, Holly Soares, Joseph F. Quinn, Jeffrey Kaye, Donald J. Connor, Nina Silverberg, Charles H. Adler, James D. Seward, Thomas G. Beach, Marwan N. Sabbagh - Alzheimer s & Dementia 2008 被引用: 410